APA (7th ed.) Citation

M, K., T, M., K, Y., R, O., H, M., M, M., . . . F, T. (2025). Immune checkpoint inhibitors in the treatment of pleural mesothelioma: Insights from real-world data. International journal of clinical oncology, 30(4), 705. https://doi.org/10.1007/s10147-025-02706-4

Chicago Style (17th ed.) Citation

M, Kanayama, Manabe T, Yoshimatsu K, Oyama R, Matsumiya H, Mori M, Takenaka M, Kuroda K, and Tanaka F. "Immune Checkpoint Inhibitors in the Treatment of Pleural Mesothelioma: Insights from Real-world Data." International Journal of Clinical Oncology 30, no. 4 (2025): 705. https://doi.org/10.1007/s10147-025-02706-4.

MLA (9th ed.) Citation

M, Kanayama, et al. "Immune Checkpoint Inhibitors in the Treatment of Pleural Mesothelioma: Insights from Real-world Data." International Journal of Clinical Oncology, vol. 30, no. 4, 2025, p. 705, https://doi.org/10.1007/s10147-025-02706-4.